Nithya Krishnamurthy, Razelle Kurzrock  Cancer Treatment Reviews 

Slides:



Advertisements
Similar presentations
Cell Signaling Lecture 13 and 14. Ligand-activated Notch undergoes 2 cleavages before releasing the transcription factor ADAM10: A disintegrin and Metalloprote.
Advertisements

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Specialized cell signaling pathways 2
The Wnt signaling pathway in cancer
Volume 59, Issue 5, Pages (November 2013)
David Largaespada, Nancy Ratner  Cancer Cell 
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Connecting COX-2 and Wnt in cancer
The Chromosomal Instability Pathway in Colon Cancer
Miriam Marqués, Francisco X. Real  European Urology 
Volume 12, Issue 2, Pages (February 2013)
Primary Immunodeficiencies
Victoria Sherwood, Irene M. Leigh  Journal of Investigative Dermatology 
Corona cell RNA sequencing from individual oocytes revealed transcripts and pathways linked to euploid oocyte competence and live birth  Jason C. Parks,
Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: Comparisons and current controversies  Corey J. Cain, Jennifer O. Manilay  Experimental.
Figure 5 Drugs that target WNT signalling
Nat. Rev. Urol. doi: /nrurol
The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy  John D. O’Flaherty, MB, BCh, BAO, Martin.
Nat. Rev. Nephrol. doi: /nrneph
TNF-α–induced protein 3 (A20): The immunological rheostat
Gating Immunity and Death at the Nuclear Pore Complex
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Figure 1 WNT signalling pathways
Ryan S. Gray, Isabelle Roszko, Lilianna Solnica-Krezel 
Volume 148, Issue 7, Pages (June 2015)
Hepatitis B “X” gene linked to cellular calcium release
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Volume 59, Issue 5, Pages (November 2013)
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
The Primary Cilium as a Complex Signaling Center
A New Twist in Smad Signaling
Volume 46, Issue 5, Pages (June 2012)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Dongwon Kim, Luis A. Garza  Journal of Investigative Dermatology 
The Ying and Yang of Bacterial Signaling in Necrotizing Enterocolitis
Axis Formation— β-Catenin Catches a Wnt
Wnt/β-catenin signaling and kidney fibrosis
The RAS/MAPK Axis Gets Stressed Out
CDK Inhibitors: Cell Cycle Regulators and Beyond
A Versatile Transcriptional Effector of Wingless Signaling
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Volume 19, Issue 5, Pages (September 2005)
Ekaterina Pak, Rosalind A. Segal  Developmental Cell 
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Wnt/β-Catenin Signaling in Development and Disease
The Expanding Cosmos of Nuclear Receptor Coactivators
EMT and proteinuria as progression factors
Cancer and Inflammation: An Aspirin a Day Keeps the Cancer at Bay
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Polycystic kidney disease: Cell division without a c(l)ue?
Smoothing Out Drug Resistance
A Wnt Survival Guide: From Flies to Human Disease
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
GPC5 Gene and Its Related Pathways in Lung Cancer
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Volume 119, Issue 4, Pages (October 2000)
Volume 4, Issue 4, Pages (April 2009)
Nat. Rev. Urol. doi: /nrurol
Notch signaling from tumor cells: A new mechanism of angiogenesis
Overview of molecular JAK signaling.
Periodic Activation of Wnt/β-Catenin Signaling Enhances Somatic Cell Reprogramming Mediated by Cell Fusion  Frederic Lluis, Elisa Pedone, Stefano Pepe,
Sclerostin and DKK1: new players in renal bone and vascular disease
Update on glucocorticoid action and resistance
Skp2, the FoxO1 hunter Cancer Cell
Presentation transcript:

Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors  Nithya Krishnamurthy, Razelle Kurzrock  Cancer Treatment Reviews  Volume 62, Pages 50-60 (January 2018) DOI: 10.1016/j.ctrv.2017.11.002 Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 1 The Wnt pathway can be classified as canonical and non-canonical. In the canonical pathway, Wnt signaling when it is on inhibits the degradation of β-catenin, which can regulate transcription of many genes. Wnt signaling is activated by binding of Wnt proteins to surface receptors composed of the seven transmembrane frizzled proteins and the LRP5/6. Upon binding, the cytoplasmic protein disheveled (Dvl) is activated. Activation of Dvl induces the dissociation of GSK-3β from Axin and leads to the inhibition of GSK-3β. Next, the phosphorylation and degradation of β-catenin is inhibited because of the inactivation of the “destruction complex”. Subsequently, stabilized β-catenin translocates into the nucleus leading to transcription of target genes like C -Myc and Cyclin D1. RNF43 (Ring finger protein 43)/ZNRF3 promote FZD receptor turnover. R-spondins or RSPO’s bind to RNF43/ZNRF3 causing their ubiquitination and clearance, resulting in increased cell surface FZD receptors. Cancer Treatment Reviews 2018 62, 50-60DOI: (10.1016/j.ctrv.2017.11.002) Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 2a Canonical Wnt Pathway and Inhibitors of the Wnt/beta-Catenin Signaling Pathway - schematic representation of the Canonical Wnt Pathway and pharmacologic inhibitors of the Wnt/beta-catenin signaling pathway. Cancer Treatment Reviews 2018 62, 50-60DOI: (10.1016/j.ctrv.2017.11.002) Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 2b Non-Canonical Wnt Pathway and the Notch and Sonic Hedgehog Pathway-The two major non-canonical pathways are Wnt/calcium and Planar Cell Polarity (PCP) pathways. In the Wnt/calcium pathway, Wnt binding to Frizzled activates Dvl, causing calcium release from the endoplasmic reticulum, activating calcium-binding proteins including protein kinase C (PKC) and calmodulin-dependent kinase II (CamKII). Signal transduction through Ca2+ activates the nuclear factor of activated T cells (NFAT). The Wnt/PCP pathway is mediated by the GTPases RhoA and Ras, which through the RhoA-Rho-associated kinase (ROCK) axis or JNK, can exert effects on the cytoskeleton. A schematic of the Notch and Sonic Hedgehog pathway is shown. Cancer Treatment Reviews 2018 62, 50-60DOI: (10.1016/j.ctrv.2017.11.002) Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 3 Cross-Talk between the Wnt, Notch and Sonic Hedgehog Pathways-Beta-catenin can drive activation of Notch signaling by increasing expression of the JAG1 gene, which encodes the Notch ligand Jagged1. Sfrp-1 may be a negative regulator for both SHH and Wnt/beta-catenin pathway. Cancer Treatment Reviews 2018 62, 50-60DOI: (10.1016/j.ctrv.2017.11.002) Copyright © 2017 Elsevier Ltd Terms and Conditions

Cancer Treatment Reviews 2018 62, 50-60DOI: (10.1016/j.ctrv.2017.11.002) Copyright © 2017 Elsevier Ltd Terms and Conditions